IBDEI1QO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31126,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,31126,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,31127,0)
 ;;=M34.1^^190^1932^91
 ;;^UTILITY(U,$J,358.3,31127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31127,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,31127,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,31127,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,31128,0)
 ;;=M34.2^^190^1932^274
 ;;^UTILITY(U,$J,358.3,31128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31128,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,31128,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,31128,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,31129,0)
 ;;=M34.81^^190^1932^276
 ;;^UTILITY(U,$J,358.3,31129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31129,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,31129,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,31129,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,31130,0)
 ;;=M34.82^^190^1932^277
 ;;^UTILITY(U,$J,358.3,31130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31130,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,31130,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,31130,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,31131,0)
 ;;=M34.83^^190^1932^278
 ;;^UTILITY(U,$J,358.3,31131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31131,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,31131,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,31131,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,31132,0)
 ;;=M34.89^^190^1932^275
 ;;^UTILITY(U,$J,358.3,31132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31132,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,31132,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,31132,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,31133,0)
 ;;=M34.9^^190^1932^279
 ;;^UTILITY(U,$J,358.3,31133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31133,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,31133,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,31133,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,31134,0)
 ;;=R21.^^190^1932^258
 ;;^UTILITY(U,$J,358.3,31134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31134,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,31134,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,31134,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,31135,0)
 ;;=R23.3^^190^1932^270
 ;;^UTILITY(U,$J,358.3,31135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31135,1,3,0)
 ;;=3^Spontaneous Ecchymoses
 ;;^UTILITY(U,$J,358.3,31135,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,31135,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,31136,0)
 ;;=L03.113^^190^1932^112
 ;;^UTILITY(U,$J,358.3,31136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31136,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,31136,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,31136,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,31137,0)
 ;;=L03.114^^190^1932^105
 ;;^UTILITY(U,$J,358.3,31137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31137,1,3,0)
 ;;=3^Cellulitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,31137,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,31137,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,31138,0)
 ;;=L03.115^^190^1932^109
 ;;^UTILITY(U,$J,358.3,31138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31138,1,3,0)
 ;;=3^Cellulitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,31138,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,31138,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,31139,0)
 ;;=L03.116^^190^1932^102
 ;;^UTILITY(U,$J,358.3,31139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31139,1,3,0)
 ;;=3^Cellulitis of Left Lower Limb
